RDY241220P12000
- 0.07
- 0.000.00%
Dr. Reddy's Laboratories Newsroom
Coya Therapeutics Highlights Strategic Vision Under New CEO, With Key 2025 Milestones Including ALS Trial With Dr. Reddy's Partnership Worth Up To $700M, Emerging Opportunities In Parkinson's And Autoimmune Conditions, And Focus On Non-Dilutive...
US Manufacturing Index Rises To 43, Highest Since 2020
Asian Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
Dr Reddy's Labs Is Maintained at Overweight by Barclays
Dr Reddy's Laboratories Analyst Ratings
Dr. Reddy's Q2 Earnings Miss Estimates, Global Generics Revenues Grow
Barclays Maintains Dr. Reddy's Laboratories(RDY.US) With Buy Rating, Cuts Target Price to $17
Jefferies Adjusts Dr. Reddy's Laboratories' Price Target to INR1,130 From INR1,120, Keeps at Underperform
Dr. Reddy's Laboratories' Consolidated Profit Falls in Fiscal Q2
Dr. Reddy's Reports Strong Q2FY25 Results and Strategic Expansions
usa Election Watching Guide: When will we know the election results?
①The United States election is about to enter the vote counting stage, with each state gradually closing polling stations and entering a tense tallying phase; ②The results of the 7 swing states are expected to be announced from 8 a.m. Beijing time (Georgia) to 11 a.m. (Nevada); ③Various signs indicate that this year's result announcement time will likely be earlier than 2020.
Dr. Reddy's Laboratories | 6-K: Report of foreign private issuer (related to financial reporting)
Dr. Reddy's Laboratories Limited (RDY) Q2 2025 Earnings Call Transcript Summary
Dr. Reddy's Laboratories Limited (RDY) Q2 2025 Earnings Call Transcript
Dr. Reddy's Lab Delivers 'Another Good Quarter,' CEO Says As Revenue Jumps 17%
Dr. Reddy's Q2 & H1FY25 Financial Results
Press Release: Dr. Reddy's Q2 & H1FY25 Financial Results
Express News | Dr. Reddy's Laboratories Shares Are Trading Higher After the Company Reported a Year-over-year Increase in Q2 Sales Results
Dr. Reddy's Laboratories 2Q Rev INR80.16B Vs. INR68.80B >RDY
Dr Reddy's Laboratories Q2 2025 GAAP EPS $0.18 Compared To $0.21 YoY, Sales $957.00M Compared To $821M YoY